| 臺大學術典藏 |
2022-06-27T07:02:08Z |
RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer
|
Tsai T.-H.; Su K.-Y.; Wu S.-G.; Chang Y.-L.; Luo S.-C.; Jane I.-S.; CHONG-JEN YU; Yue S.-L.; Shih J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:01:52Z |
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy
|
Tsai T.-H.; Yang C.-Y.; Ho C.-C.; Liao W.-Y.; Jan I.-S.; Chen K.-Y.; Wang J.-Y.; Ruan S.-Y.; CHONG-JEN YU; Yang J.C.H.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2022-06-27T07:01:50Z |
Clinical and the prognostic characteristics of lung adenocarcinoma patients with ros1 fusion in comparison with other driver mutations in east asian populations
|
Chen Y.-F.; Hsieh M.-S.; Wu S.-G.; Chang Y.-L.; Shih J.-Y.; Liu Y.-N.; Tsai M.-F.; Tsai T.-H.; CHONG-JEN YU; Yang J.C.-H.; Yang P.-C. |
| 臺大學術典藏 |
2022-06-27T07:01:38Z |
Clinical and prognostic implications of RET rearrangements in metastatic lung adenocarcinoma patients with malignant pleural effusion
|
Tsai T.-H.; Wu S.-G.; Hsieh M.-S.; CHONG-JEN YU; Yang J.C.H.; Shih J.-Y. |
| 臺大學術典藏 |
2022-06-27T07:00:05Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-06-27T07:00:03Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; CHONG-JEN YU; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-06-27T07:00:01Z |
Combined effect of ERCC1 and ERCC2 polymorphisms on overall survival in non-squamous non-small-cell lung cancer patients treated with first-line pemetrexed/platinum
|
Liao W.-Y.; Ho C.-C.; Tsai T.-H.; Chen K.-Y.; Shih J.-Y.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-06-27T06:59:49Z |
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
|
Lee J.-H.; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Liao W.-Y.; Shih J.-Y.; CHONG-JEN YU; Chen K.-Y.; Tsai T.-H.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-06-27T06:59:47Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-06-27T06:59:44Z |
Complex EGFR mutations with secondary T790M mutation confer shorter osimertinib progression-free survival and overall survival in advanced non-small cell lung cancer
|
Lin Y.-T.; Tsai T.-H.; Wu S.-G.; Liu Y.-N.; CHONG-JEN YU; Shih J.-Y. |
| 臺大學術典藏 |
2022-06-27T06:59:43Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; CHONG-JEN YU |
| 臺大學術典藏 |
2022-06-27T06:59:38Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC
|
Liao B.-C.; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; CHONG-JEN YU; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-05-13T08:05:00Z |
Adding moxifloxacin is associated with a shorter time to culture conversion in pulmonary tuberculosis
|
Wang J.-Y.; JANN-TAY WANG; Tsai T.-H.; Hsu C.-L.; Yu C.-J.; Hsueh P.-R.; Lee L.-N.; Yang P.-C. |
| 臺大學術典藏 |
2022-04-26T01:30:41Z |
Evaluation of discharge planning services for stroke patients with disabilities: Patient perspectives
|
Tsai T.-H.; Chuang K.-Y.; YU-TZU DAI; Tzeng S.-F.; Wu S.-C. |
| 臺大學術典藏 |
2022-04-20T07:19:07Z |
Evolution of the Prevalence of Myopia among Taiwanese Schoolchildren: A Review of Survey Data from 1983 through 2017
|
Tsai T.-H.; Liu Y.-L.; Ma I.-H.; Su C.-C.; Lin C.-W.; Lin L.L.-K.; CHUHSING KATE HSIAO; Wang I.-J. |
| 臺大學術典藏 |
2022-03-22T08:31:55Z |
Metformin-Incorporated Gelatin/Hydroxyapatite Nanofiber Scaffold for Bone Regeneration
|
Sun C.-K;Weng P.-W;Chang J.Z.-C;Lin Y.-W;Tsuang F.-Y;Lin F.-H;Tsai T.-H;Sun J.-S.; Sun C.-K; Weng P.-W; Chang J.Z.-C; Lin Y.-W; Tsuang F.-Y; Lin F.-H; Tsai T.-H; Sun J.-S.; FENG-HUEI LIN |
| 臺大學術典藏 |
2022-03-22T08:31:53Z |
Metformin-Incorporated Gelatin/Hydroxyapatite Nanofiber Scaffold for Bone Regeneration
|
Sun C.-K;Weng P.-W;Chang J.Z.-C;Lin Y.-W;Tsuang F.-Y;Lin F.-H;Tsai T.-H;Sun J.-S.; Sun C.-K; Weng P.-W; Chang J.Z.-C; Lin Y.-W; Tsuang F.-Y; Lin F.-H; Tsai T.-H; Sun J.-S.; FENG-HUEI LIN |
| 臺大學術典藏 |
2022-03-22T08:28:51Z |
Metformin-Incorporated Gelatin/Hydroxyapatite Nanofiber Scaffold for Bone Regeneration
|
Sun C.-K;Weng P.-W;Chang J.Z.-C;Lin Y.-W;Tsuang F.-Y;Lin F.-H;Tsai T.-H;Sun J.-S.; Sun C.-K; Weng P.-W; Chang J.Z.-C; Lin Y.-W; Tsuang F.-Y; Lin F.-H; Tsai T.-H; Sun J.-S.; FENG-HUEI LIN |
| 臺大學術典藏 |
2022-03-04T05:33:41Z |
Effusion immunocytochemistry as an alternative approach for the selection of first-line targeted therapy in advanced lung adenocarcinoma
|
Tsai T.-H.; Wu S.-G.; Chang Y.-L.; CHEN-TU WU; Tsai M.-F.; Wei P.-F.; Yang C.-H.; Yu C.-J.; Yang P.-C.; Shih J.-Y. |
| 臺大學術典藏 |
2022-03-04T05:33:28Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-03-04T05:33:27Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; CHEN-TU WU; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-23T02:19:48Z |
Serum indoxyl sulfate associates with postangioplasty thrombosis of dialysis grafts
|
CHIH-CHENG WU; Hsieh M.-Y.; Hung S.-C.; Kuo K.-L.; Tsai T.-H.; Lai C.-L.; Chen J.-W.; Lin S.-J.; Huang P.-H.; Tarng D.-C. |
| 臺大學術典藏 |
2022-02-22T03:37:28Z |
Central venous catheter-associated fungemia due to Wangiella dermatitidis
|
PING-HUEI TSENG; Lee P.; Tsai T.-H.; Hsueh P.-R. |
| 臺大學術典藏 |
2022-02-21T03:52:35Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; JIH-HSIANG LEE; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:35Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:33Z |
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR Inhibitors
|
JIH-HSIANG LEE; Chen H.-Y.; Hsu F.-M.; Chen J.-S.; Liao W.-Y.; Shih J.-Y.; Yu C.-J.; Chen K.-Y.; Tsai T.-H.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:32Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:31Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:30Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M�VPositive NSCLC
|
Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-14T07:10:40Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-01-17T08:00:27Z |
CCL2 increases αvβ3 integrin expression and subsequently promotes prostate cancer migration
|
Lin T.-H.; Liu H.-H.; Tsai T.-H.; Chen C.-C.; Hsieh T.-F.; Lee S.-S.; YUAN-JU LEE; Chen W.-C.; Tang C.-H. |
| 臺大學術典藏 |
2022-01-11T06:49:47Z |
Scalable production of controllable dermal papilla spheroids on PVA surfaces and the effects of spheroid size on hair follicle regeneration
|
Huang Y.-C.; Chan C.-C.; Lin W.-T.; HSIEN-YI CHIU; Tsai R.-Y.; Tsai T.-H.; Chan J.-Y.; Lin S.-J. |
| 臺大學術典藏 |
2022-01-11T06:49:42Z |
Enhancing hair follicle regeneration by nonablative fractional laser: Assessment of irradiation parameters and tissue response
|
Wu Y.-F.; Wang S.-H.; Wu P.-S.; Fan S.M.-Y.; HSIEN-YI CHIU; Tsai T.-H.; Lin S.-J. |
| 臺大學術典藏 |
2021-12-22T03:54:31Z |
Aggrenox (Asasantin retard)-induced Stevens-Johnson syndrome
|
Jao T.; Tsai T.-H.; JIANN-SHING JENG |
| 臺大學術典藏 |
2021-11-03T05:24:55Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC
|
Liao B.-C.; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; CHONG-JEN YU; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-11-03T02:33:02Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC
|
Liao B.-C.; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; JIN-YUAN SHIH; Yu C.-J.; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-09-17T05:41:26Z |
The value of radial endobronchial ultrasound-guided bronchial brushing in peripheral non-squamous non-small cell lung cancer
|
KAI-LUN YU; Tsai T.-H.; Ho C.-C.; Liao W.-Y.; Lin C.-K.; Hsu C.-L.; Shih J.-Y. |
| 臺大學術典藏 |
2021-09-15T01:21:00Z |
Characterization of the neuropsychological phenotype of glycine N-methyltransferase-/- mice and evaluation of its responses to clozapine and sarcosine treatments
|
Yang C.-P.; Wang H.-A.; Tsai T.-H.; Fan A.; CHIA-LANG HSU; Chen C.-J.; Hong C.-J.; Chen Y.M.A. |
| 臺大學術典藏 |
2021-09-02T00:05:10Z |
36-40 GHz TX/RX beamformers for 5G mm-wave phased-array
|
Chen C.-N;Lin Y.-H;Liu Y.-L;Liao W.-J;Nien Y.-H;Lu H.-C;Tsai T.-H;Huang T.-W;Wang H.; Chen C.-N; Lin Y.-H; Liu Y.-L; Liao W.-J; Nien Y.-H; Lu H.-C; Tsai T.-H; Huang T.-W; Wang H.; HUEI WANG |
| 臺大學術典藏 |
2021-09-02T00:05:06Z |
A 38-GHz 32-Element phased-array transmitter based on scalable 8-Element phased-array modules for 5G MMW data links
|
Chen C.-N;Hung L.-C;Lin Y.-H;Tang T.-C;Chao W.-P;Lin G.-Y;Liao W.-J;Nien Y.-H;Huang W.-C;Kuo T.-Y;Lin K.-Y;Huang T.-W;Lin Y.-C;Lu H.-C;Tsai T.-H;Wang H.; Chen C.-N; HUEI WANG et al. |
| 臺大學術典藏 |
2021-09-02T00:05:03Z |
38-GHz Phased Array Transmitter and Receiver Based on Scalable Phased Array Modules with Endfire Antenna Arrays for 5G MMW Data Links
|
Chen C.-N;Lin Y.-H;Hung L.-C;Tang T.-C;Chao W.-P;Chen C.-Y;Chuang P.-H;Lin G.-Y;Liao W.-J;Nien Y.-H;Huang W.-C;Kuo T.-Y;Lin K.-Y;Huang T.-W;Lin Y.-C;Lu H.-C;Tsai T.-H;Wang H.; Chen C.-N; HUEI WANG et al. |
| 臺大學術典藏 |
2021-09-02T00:04:57Z |
38-GHz Phased Array Transmitter and Receiver Based on Scalable Phased Array Modules with Endfire Antenna Arrays for 5G MMW Data Links
|
Chen C.-N;Lin Y.-H;Hung L.-C;Tang T.-C;Chao W.-P;Chen C.-Y;Chuang P.-H;Lin G.-Y;Liao W.-J;Nien Y.-H;Huang W.-C;Kuo T.-Y;Lin K.-Y;Huang T.-W;Lin Y.-C;Lu H.-C;Tsai T.-H;Wang H.; Chen C.-N; HSIN-CHIA LU et al. |
| 臺大學術典藏 |
2021-08-31T03:33:45Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
SHU-YUNG LIN; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-20T08:00:40Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; BIN-CHI LIAO; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-20T08:00:39Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; BIN-CHI LIAO; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-20T08:00:38Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; BIN-CHI LIAO; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2021-08-20T08:00:38Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M�VPositive NSCLC
|
BIN-CHI LIAO; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-08-05T02:41:52Z |
Transglutaminase cross-linked gelatin-alginate-antibacterial hydrogel as the drug delivery-coatings for implant-related infections
|
Sun C.-K;Ke C.-J;Lin Y.-W;Lin F.-H;Tsai T.-H;Sun J.-S.; Sun C.-K; Ke C.-J; Lin Y.-W; Lin F.-H; Tsai T.-H; Sun J.-S.; FENG-HUEI LIN |
| 臺大學術典藏 |
2021-07-21T08:21:18Z |
Relationships between autistic traits, insufficient sleep, and real-world executive functions in children: A mediation analysis of a national epidemiological survey
|
Tsai T.-H.; Chen Y.-L.; SUSAN SHUR-FEN GAU |
| 臺大學術典藏 |
2021-07-13T06:04:33Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; LEE JIH-HSIANG; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
